Liquid Biopsy Accurately Detects Key Genetic Mutations in Most Common Form of Lung Cancer
Study demonstrates the test’s potential as a clinical tool for identifying patients who can benefit from drugs targeting specific mutations.
Read MoreSearch Results for: lung cancer
April 2016 Product News
This month’s Product News features a blood-based mutation test, storage racks, an electrophoresis system, and tissue analysis software.
Read More
NIH Team Identifies Genomic Signature Shared by Five Types of Cancer
Researchers hope to spur development of a blood test that can be used to diagnose a variety of cancers at early stages.
Read More
Developing and Marketing an FDA-Regulated Test
Exact Sciences overcame significant obstacles to bring cancer screening innovation to patients.
Read More
Enhancements Added to Blood-Based Mutation Test
The GeneStrat noninvasive, blood-based test is designed to provide accurate results in 72 hours for newly diagnosed non-small cell lung cancer patients.
Read More